Filing Details

Accession Number:
0001181431-12-060801
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-28 15:33:26
Reporting Period:
2012-11-26
Filing Date:
2012-11-28
Accepted Time:
2012-11-28 15:33:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267878 W Todd Kingma C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-11-21 650 $0.00 1,736 No 5 G Indirect By Trust
Common Stock Acquisiton 2012-11-26 2,740 $30.06 21,205 No 4 M Direct
Common Stock Disposition 2012-11-26 2,740 $103.28 18,465 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By Trust
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2012-11-26 2,740 $0.00 2,740 $30.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-08-25 2019-08-25 No 4 M Direct
Footnotes
  1. By Trust, of which the reporting person is the Trustee.
  2. This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on March 7, 2012. This 10b5-1 sales plan will expire on the close of business December 31, 2012.
  3. The price in column 4 is a weighted average. The prices actually received ranged from $103.12 to $103.89. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.